Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share
Go back to Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share| Quest Diagnostics (NYSE: DGX) | Delayed: 246.45 -1 (0.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $247.45 | 52 Week High | $86.85 | |||
| Open | $246.52 | 52 Week Low | $59.66 | |||
| Day High | $247.63 | P/E | 46.41 | |||
| Day Low | $244.89 | EPS | $5.31 | |||
| Volume | 1,925,637 | |||||
